Opexa Pharmaceuticals, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, December 14, 2011, at 11:40 a.m. EST. The conference will be held at The Waldorf – Astoria Hotel in New York City.

Back to news